FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20200529E00040
1. Date of relevant event: 26/05/2020
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 03681
4. Name of listed corporation: SinoMab BioScience Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 1,006,240,400
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) LEUNG
(Other names) Shui On
10. Name of director (Chinese): 梁瑞安 
11. Chinese Character Code as printed on HKID Card: 273338431344
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1316There has been a change in nature of your interest in the shares because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
2401A concert party to an agreement to buy shares described in s.317(1)(a)
 
2501Other (you must describe the capacity in the Supplementary Information box)
 
41,331,640  HKD      3.5000 
3101Cash
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position389,469,20038.71
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position389,469,20038.71
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position178,843,600
2401A concert party to an agreement to buy shares described in s.317(1)(a)
Long position210,625,600
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Skytech Technology LimitedSea Meadow House, Blackburne Highway, PO Box 116, Road Town, Tortola, British Virgin IslandsShui On LEUNG100.00Y
Long position178,843,600
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
Skytech Technology LimitedAddresses of individuals are not displayed.178,843,600
Forbest Capital Investment Group LimitedAddresses of individuals are not displayed.199,476,400
Kwan Yin SIUAddresses of individuals are not displayed.1,340,000
Ming Hon YAUAddresses of individuals are not displayed.2,000,000
Ka Wa Benny CHEUNGAddresses of individuals are not displayed.1,340,000
Kwan Yeung LEEAddresses of individuals are not displayed.1,060,000
Chau Yin Janet TSUIAddresses of individuals are not displayed.4,349,200
Guolin XUAddresses of individuals are not displayed.1,060,000
Total number of shares in which a director is interested under sections 317 and 318210,625,600
 
34. Supplementary information: Pursuant to the Sale and Purchase Agreement dated 26 May 2020 made between, among others, Forbest Capital Investment Group Limited ("Forbest Capital") and Grogene Technology Limited ("Grogene"), Forbest Capital agreed to sell 41,331,640 shares of SinoMab BioScience Limited to Grogene at a price of HK$3.50 per share. Completion of the said Agreement is conditional upon all the Conditions (as defined threin) having been satisfied as stipulated therein.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded: 1
A0000000000000568022.pdf
Date of filing this Form 3A: 29/05/2020
(dd/mm/yyyy)